Publications

5255 Results

Relevance of bone marrow biopsies for response assessment in U.S. National Cancer Institute National Clinical Trials Network follicular lymphoma clinical trials

Authors
S Rutherford;J Yin;L Pederson;G Perez Burbano;P LaPlant;M Shadman;H Li;M LeBlanc;V Kenkre;F Hong;K Blum;T Dockter;P Martin;S Jung;B Grant;C Rosenbaum;C Ujjani;P Barr;J Unger;B Cheson;N Bartlett;B Kahl;JW Friedberg;S Mandrekar;J Leonard
Journal / Conference
Journal of Clinical Oncology 10;41(2):336-342
Year
2023
Research Committee(s)
Lymphoma
PMID
PMID35787017
PMC
PMID35787017
Study Number(s)
S0016, S0801

Acquired Genomic Alterations on First Line Chemotherapy with Cetuximab/Bevacizumab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of CALGB/SWOG-80405 Trial

Authors
K Raghav;F-S Ou;A Venook;F Innocenti;R Sun;H-J Lenz;ES Kopetz
Journal / Conference
Journal of Clinical Oncology Jan 20;41(3):472-478
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID36067452
PMC
PMC9870237
Study Number(s)
CTSU/C80405

Phase III Prospectively Randomized Trial of Perioperative 5-FU after Curative Resection, Followed by 5-FU/Leucovorin for Patients with Colon Cancer- Intergroup: A trial of the ECOG-ACRIN Research Group (E1292)

Authors
MM Kemeny;F Zhao;A Forastiere;P Catalano;D Heimann;SR Hamilton;B Meidema;N Dawson;LM Weiner;B Smith;BA Mason;S Graziano;PB Gilman;A Venook;H Pinto;RP Whitehead;PJ O'Dwyer;AB Benson
Journal / Conference
Annals Surgical Oncology Feb;30(2):1099-1109
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID36305992
PMC
PMC9807536

A Pragmatic Cluster-Randomized Trial of a Standing Physician Order Entry Intervention for Colony Stimulating Factor use among Patients at Intermediate Risk for Febrile Neutropenia (TrACER) (SWOG S1415)

Authors
D Hershman;A Bansal;S Sullivan;G Lyman;W Barlow;K Arnold;K Watabayashi;A Bell-Brown;N Le-Lindqwister;C Dul;U Brown-Glaberman;R Behrens;V Vogel;N Alluri;S Ramsey
Journal / Conference
Journal of Clinical Oncology Jan 20;41(3):590-598
Year
2023
Research Committee(s)
Cancer Care Delivery
PMID
PMID36228177
PMC
PMC9870230
Study Number(s)
S1415CD

The impact of early PEG-asparaginase discontinuation in young adults with ALL: A post hoc analysis of the C10403 study

Authors
I Aldoss;J Yin;A Wall;K Mrozek;M Liedtke;D Claxton;M Foster;F Appelbaum;H Erba;M Litzow;M Tallman;R Stone;A Advani;W Stock;S Luger
Journal / Conference
Blood Advances Jan 24;7(2):196-204
Year
2023
Research Committee(s)
Leukemia
PMID
PMID36269846
PMC
PMC9841239
Study Number(s)
C10403

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134

Authors
M Atkins;S Lee;B Chmielowski;A Tarhini;Moon Truong;D Davar;M O'Rourke;B Curti;J Brell;K Kendra;A Ikeguchi;A Wolchok;A Ribas;J Kirkwood
Journal / Conference
Journal of Clinical Oncology Jan 10;41(2):186-197
Year
2023
Research Committee(s)
Melanoma
PMID
PMID36166727
PMC
PMC9839305
Study Number(s)
CTSU/EA6134

Adjuvant pembrolizumab improves quality-of-life outcomes compared to high dose interferon or ipilimumab in patients with resected melanoma; SWOG S1404, A Randomized Clinical Trial

Authors
J Unger;A Darke;M Othus;A Tarhini;J Kirkwood;E Sharon;V Sondak;S Guild;T Truong;Z Eroglu;K Kendra;K Lewis;B Faller;P Funchain;E Buchbinder;K Grossmann;A Ribas;S Patel
Journal / Conference
JAMA Oncology Feb 1;9(2):251-260
Year
2023
Research Committee(s)
Melanoma
PMID
PMID36416836
PMC
PMC9685550
Study Number(s)
S1404

Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy from Adjuvant Therapy in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

Authors
S Lee;C Ma;Q Shi;P Kumar;F Coutoure;JP Kuebler;S Krishnamurthi;D Lewis;B Tan;R Goldberg;A Venook;CD Blanke;E O'Reilly;A Shields;J Meyerhardt
Journal / Conference
Journal of Clinical Oncology Feb 10;41(5):1079-1091
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID36367997
PMC
PMC9928634
Study Number(s)
CTSU/C80702

Early Mortality Risk with Non-Intensive Acute Myeloid Leukemia (AML) Therapies: Analysis of 1,336 Patients from MRC/NCRI and SWOG

Authors
M Othus;I Thomas;X Wang;C Ariti;P Mehta;M Sydenham;R Hills;A Burnett;S Nand;S Assouline;L Michaelis;H Erba;N Russell;K Kerr;R Walter;M Dennis
Journal / Conference
Leukemia and Lymphoma Jan;64(1):250-252
Year
2023
Research Committee(s)
Leukemia and Symptom Control and Quality of Life
PMID
PMID36226777
Study Number(s)
S0432, S0702, S1612

Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)

Authors
J Brown;C Ma;Q Shi;C Fuchs;J Meyer;D Niedzwiecki;T Zemla;F Couture;P Kuebler;P Kumar;D Lewis;B Tan;E O'Reilly;AF Shields;J Meyerhardt
Journal / Conference
Journal of Clinical Oncology Jan 10;41(2):243-254
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID35944235
PMC
PMC9839249
Study Number(s)
CTSU/C80702